New open-source scripts

wordperfectI wanted to go ahead and put out there some new scripts that I have recently developed.  These include:

BagIt Validation Script
For a given directory, this script validates all the “BagIt” bags in it, and send an email to a designated email address with the status of the bags.  BagIt is a standard and a software originally developed by Library of Congress that is used to confirm the integrity of collections of files (e.g., not files deleted, no files tampered with, no files suffering from bit-rot/bit-corruption/etc.).  Written with Python and tested on Windows.

File Normalization tools: WordPerfect to PDF
Doing born-digital archives work almost always seems to turn-up WordPerfect (WPD) files.  This script will go thru a directory, including all subdirectories, and create PDF verisons of all WPD files using MS Word for Windows.  Requires Windows XP+ and MS Word for Windows.

Review: Access to Knowledge in the Age of Intellectual Property

I reviewed the book, Access to Knowledge in the Age of Intellectual Property from Zone Books/MIT Press (2010). It appears here in the Teachers College Record. The review is below:

Access to Knowledge in the Age on Intellectual Property is a collection of over 30 essays by an international body of scholars, lawyers, and activists, detailing the “access to knowledge” movement, or “A2K” for short. A2K is an emerging movement most succinctly described as a reaction to the global expansion of intellectual property law. Adherents to the movement detail the deleterious effects such expansion has had individual ability to access information and build knowledge, especially in the developing world. Such expansion is not only a problem for education, but also for human health. Because many medications are protected by intellectual property law, such as those for treating HIV/AIDS, access to those medicines has become prohibitively expensive for much of the developing world. It is not the cost of manufacturing the drug, but rather the idea of the drug (owned largely by western pharmaceutical companies, such as Pfizer, Bristol-Meyer Squibb, among others) where most of the cost lies.

Continue reading “Review: Access to Knowledge in the Age of Intellectual Property”